vs
Side-by-side financial comparison of EVOLUTION PETROLEUM CORP (EPM) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
EVOLUTION PETROLEUM CORP is the larger business by last-quarter revenue ($20.7M vs $13.8M, roughly 1.5× FENNEC PHARMACEUTICALS INC.). EVOLUTION PETROLEUM CORP runs the higher net margin — 5.2% vs -34.7%, a 39.9% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 2.0%). Over the past eight quarters, EVOLUTION PETROLEUM CORP's revenue compounded faster (-5.2% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
EPM vs FENC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $13.8M |
| Net Profit | $1.1M | $-4.8M |
| Gross Margin | 44.3% | — |
| Operating Margin | 3.2% | -18.5% |
| Net Margin | 5.2% | -34.7% |
| Revenue YoY | 2.0% | 73.8% |
| Net Profit YoY | 158.4% | -141.1% |
| EPS (diluted) | $0.03 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | $13.8M | ||
| Q3 25 | $21.3M | $12.5M | ||
| Q2 25 | $21.1M | $9.7M | ||
| Q1 25 | $22.6M | $8.8M | ||
| Q4 24 | $20.3M | $7.9M | ||
| Q3 24 | $21.9M | $7.0M | ||
| Q2 24 | $21.2M | $7.3M | ||
| Q1 24 | $23.0M | $25.4M |
| Q4 25 | $1.1M | $-4.8M | ||
| Q3 25 | $824.0K | $-638.0K | ||
| Q2 25 | $3.4M | $-3.2M | ||
| Q1 25 | $-2.2M | $-1.2M | ||
| Q4 24 | $-1.8M | $-2.0M | ||
| Q3 24 | $2.1M | $-5.7M | ||
| Q2 24 | $1.2M | $-5.6M | ||
| Q1 24 | $289.0K | $12.8M |
| Q4 25 | 44.3% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 46.1% | — | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 46.2% | — | ||
| Q2 24 | 46.3% | — | ||
| Q1 24 | 45.2% | — |
| Q4 25 | 3.2% | -18.5% | ||
| Q3 25 | -0.4% | -1.5% | ||
| Q2 25 | 6.3% | -28.3% | ||
| Q1 25 | 7.0% | -9.2% | ||
| Q4 24 | -3.0% | -11.8% | ||
| Q3 24 | 8.5% | -74.6% | ||
| Q2 24 | 11.3% | -69.4% | ||
| Q1 24 | 9.1% | 54.2% |
| Q4 25 | 5.2% | -34.7% | ||
| Q3 25 | 3.9% | -5.1% | ||
| Q2 25 | 16.2% | -32.7% | ||
| Q1 25 | -9.7% | -13.3% | ||
| Q4 24 | -9.0% | -25.0% | ||
| Q3 24 | 9.4% | -82.2% | ||
| Q2 24 | 5.8% | -76.5% | ||
| Q1 24 | 1.3% | 50.6% |
| Q4 25 | $0.03 | $-0.17 | ||
| Q3 25 | $0.02 | $-0.02 | ||
| Q2 25 | $0.10 | $-0.11 | ||
| Q1 25 | $-0.07 | $-0.04 | ||
| Q4 24 | $-0.06 | $-0.02 | ||
| Q3 24 | $0.06 | $-0.21 | ||
| Q2 24 | $0.04 | $-0.20 | ||
| Q1 24 | $0.01 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.8M | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $67.5M | $35.5M |
| Total Assets | $169.3M | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $36.8M | ||
| Q3 25 | $714.0K | $21.9M | ||
| Q2 25 | $2.5M | $18.7M | ||
| Q1 25 | $5.6M | $22.7M | ||
| Q4 24 | $11.7M | $26.6M | ||
| Q3 24 | $6.9M | $40.3M | ||
| Q2 24 | $6.4M | $43.1M | ||
| Q1 24 | $3.1M | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $67.5M | $35.5M | ||
| Q3 25 | $69.1M | $-4.5M | ||
| Q2 25 | $71.8M | $-7.5M | ||
| Q1 25 | $71.7M | $-5.9M | ||
| Q4 24 | $76.3M | $-5.9M | ||
| Q3 24 | $79.6M | $-5.2M | ||
| Q2 24 | $81.1M | $-1.4M | ||
| Q1 24 | $83.5M | $3.0M |
| Q4 25 | $169.3M | $70.6M | ||
| Q3 25 | $169.1M | $49.3M | ||
| Q2 25 | $160.3M | $44.9M | ||
| Q1 25 | $156.4M | $46.4M | ||
| Q4 24 | $160.2M | $44.9M | ||
| Q3 24 | $157.9M | $58.9M | ||
| Q2 24 | $162.9M | $63.2M | ||
| Q1 24 | $166.5M | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-6.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 5.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-6.0M | ||
| Q3 25 | $7.8M | $1.5M | ||
| Q2 25 | $10.5M | $-3.7M | ||
| Q1 25 | $7.3M | $-4.3M | ||
| Q4 24 | $7.7M | $-1.5M | ||
| Q3 24 | $7.6M | $-2.2M | ||
| Q2 24 | $8.0M | $-8.4M | ||
| Q1 24 | $3.4M | $39.0M |
| Q4 25 | 5.09× | — | ||
| Q3 25 | 9.47× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.69× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 11.64× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |
FENC
Segment breakdown not available.
